Inventor
Sarah Spiegel
Inventor
Richmond, VA, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds14%
C07CAcyclic or carbocyclic compounds13%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
A61BDiagnosis2%
A61GTransport, personal conveyances, or accommodation specially adapted for patients or disabled persons2%
A61HPhysical therapy apparatus, e.g. devices for locating or stimulating reflex points in the body2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
10,893,997Rehabilitation mechanism for patients confined to bed202110,624,863Sphingosine kinase type 1 inhibitors and uses thereof202010,456,370Sphingosine kinase type 1 inhibitors and uses thereof201910,166,204Sphingosine kinase type 1 inhibitors and uses thereof20199,974,758Sphingosine kinase type 1 inhibitors and uses thereof20189,598,384'3-(2-amino-ethyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-alkylidene-1,3-dihydro-indol-2-one derivatives as selective sphingosine kinase 2 inhibitors'20179,388,121'Sphingosine kinase type 1 inhibitors'20168,372,888'Sphingosine kinase type 1 inhibitors, compositions and processes for using same'20138,314,151'Sphingosine kinase type 1 inhibitors, and processes for using same'20128,263,349'Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof'20127,803,595'Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof'20107,419,814'Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof'20086,830,916'Sphingosine kinase, cloning, expression and methods of use'20046,800,470'Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof'20045,714,478'Sphingosylphosphorylcholine as a wound-healing agent'19985,712,262'Use of sphingosine-1-phosphate to suppress programmed cell death'19985,374,616'Compositions containing sphingosylphosphorylcholine and the use thereof as a cellular growth factor'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2012Patents assigned to UNIV GEORGETOWN (5)· patent assignee history
1994Based in Potomac, MD, US· patent location history
1998–2012Based in McLean, VA, US· patent location history
2004–2012Patents assigned to SANKYO CO (4)· patent assignee history
2012–2020Patents assigned to ENZO THERAPEUTICS INC (7)· patent assignee history
2012–2020Patents assigned to UNIV VIRGINIA COMMONWEALTH (7)· patent assignee history
2012–2013Patents assigned to SPIEGEL SARAH (3)· patent assignee history
2012–2020Based in Richmond, VA, US· patent location history
2021Based in Munich, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ENZO THERAPEUTICS INC | 7 | 2012–2020 |
| UNIV VIRGINIA COMMONWEALTH | 7 | 2012–2020 |
| UNIV GEORGETOWN | 5 | 1994–2012 |
| SANKYO CO | 4 | 2004–2012 |
| SPIEGEL SARAHself | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Richmond, Virginia, US | 8 | 2012–2020 |
| McLean, Virginia, US | 7 | 1998–2012 |
| Munich, DE | 1 | 2021 |
| Potomac, Maryland, US | 1 | 1994 |